122 related articles for article (PubMed ID: 9267779)
1. Biphasic effects of carbamazepine on the dopaminergic system in rat striatum and hippocampus.
Okada M; Hirano T; Mizuno K; Chiba T; Kawata Y; Kiryu K; Wada K; Tasaki H; Kaneko S
Epilepsy Res; 1997 Sep; 28(2):143-53. PubMed ID: 9267779
[TBL] [Abstract][Full Text] [Related]
2. Effects of zonisamide on dopaminergic system.
Okada M; Kaneko S; Hirano T; Mizuno K; Kondo T; Otani K; Fukushima Y
Epilepsy Res; 1995 Nov; 22(3):193-205. PubMed ID: 8991786
[TBL] [Abstract][Full Text] [Related]
3. [Effects of carbamazepine and zonisamide on dopaminergic system in rat striatum and hippocampus].
Okada M
Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Oct; 14(5):337-54. PubMed ID: 7856330
[TBL] [Abstract][Full Text] [Related]
4. Effects of carbamazepine on hippocampal serotonergic system.
Okada M; Hirano T; Mizuno K; Kawata Y; Wada K; Murakami T; Tasaki H; Kaneko S
Epilepsy Res; 1998 Aug; 31(3):187-98. PubMed ID: 9722029
[TBL] [Abstract][Full Text] [Related]
5. Effects of carbamazepine on acetylcholine release and metabolism.
Mizuno K; Okada M; Murakami T; Kamata A; Zhu G; Kawata Y; Wada K; Kaneko S
Epilepsy Res; 2000 Jul; 40(2-3):187-95. PubMed ID: 10863146
[TBL] [Abstract][Full Text] [Related]
6. A kinetic analysis of the effects of beta-phenylethylamine on the concentrations of dopamine and its metabolites in the rat striatum.
Sato S; Tamura A; Kitagawa S; Koshiro A
J Pharm Sci; 1997 Apr; 86(4):487-96. PubMed ID: 9109054
[TBL] [Abstract][Full Text] [Related]
7. Increased dopaminergic and 5-hydroxytryptaminergic activities in male rat brain following long-term treatment with anabolic androgenic steroids.
Thiblin I; Finn A; Ross SB; Stenfors C
Br J Pharmacol; 1999 Mar; 126(6):1301-6. PubMed ID: 10217522
[TBL] [Abstract][Full Text] [Related]
8. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis.
Hara S; Mukai T; Kurosaki K; Kuriiwa F; Endo T
Arch Toxicol; 2002 Oct; 76(10):596-605. PubMed ID: 12373456
[TBL] [Abstract][Full Text] [Related]
9. Effects of d-amphetamine on dopaminergic neurotransmission; a comparison between the substantia nigra and the striatum.
Elverfors A; Nissbrandt H
Neuropharmacology; 1992 Jul; 31(7):661-70. PubMed ID: 1328918
[TBL] [Abstract][Full Text] [Related]
10. Coadministration of β-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa: a different mechanism from Madopar.
Huang L; Deng M; Zhang S; Fang Y; Li L
Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):685-90. PubMed ID: 24910244
[TBL] [Abstract][Full Text] [Related]
11. Dopamine metabolism in the striatum of hemiparkinsonian model rats with dopaminergic grafts.
Hashitani T; Mizukawa K; Kumazaki M; Nishino H
Neurosci Res; 1998 Jan; 30(1):43-52. PubMed ID: 9572579
[TBL] [Abstract][Full Text] [Related]
12. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
Lamensdorf I; Youdim MB; Finberg JP
J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
[TBL] [Abstract][Full Text] [Related]
13. L-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors.
Wachtel SR; Abercrombie ED
J Neurochem; 1994 Jul; 63(1):108-17. PubMed ID: 8207420
[TBL] [Abstract][Full Text] [Related]
14. Modulation of dihydroxyphenylacetaldehyde extracellular levels in vivo in the rat striatum after different kinds of pharmacological treatment.
Fornai F; Giorgi FS; Bassi L; Ferrucci M; Alessandrì MG; Corsini GU
Brain Res; 2000 Apr; 861(1):126-34. PubMed ID: 10751572
[TBL] [Abstract][Full Text] [Related]
15. Influence of selective inhibition of monoamine oxidase A or B on striatal metabolism of L-DOPA in hemiparkinsonian rats.
Finberg JP; Wang J; Goldstein DS; Kopin IJ; Bankiewicz KS
J Neurochem; 1995 Sep; 65(3):1213-20. PubMed ID: 7643100
[TBL] [Abstract][Full Text] [Related]
16. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
Ilani T; Lamensdorf I; Finberg JP
Br J Pharmacol; 2000 Aug; 130(8):1992-8. PubMed ID: 10952692
[TBL] [Abstract][Full Text] [Related]
17. [Effects of carbamazepine and zonisamide on acetylcholine levels in rat striatum].
Mizuno K
Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Feb; 17(1):17-23. PubMed ID: 9134534
[TBL] [Abstract][Full Text] [Related]
18. Turnover of dopamine and dopamine metabolites in rat brain: comparison between striatum and substantia nigra.
Nissbrandt H; Carlsson A
J Neurochem; 1987 Sep; 49(3):959-67. PubMed ID: 3612134
[TBL] [Abstract][Full Text] [Related]
19. N-methyl-d-aspartate receptors modulate extracellular dopamine concentration and metabolism in rat hippocampus and striatum in vivo.
Whitton PS; Maione S; Biggs CS; Fowler LJ
Brain Res; 1994 Jan; 635(1-2):312-6. PubMed ID: 8173968
[TBL] [Abstract][Full Text] [Related]
20. Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys.
Di Monte DA; DeLanney LE; Irwin I; Royland JE; Chan P; Jakowec MW; Langston JW
Brain Res; 1996 Oct; 738(1):53-9. PubMed ID: 8949927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
